These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Increased concentrations of plasma neuropeptide Y in patients with eclampsia and preeclampsia. Author: Khatun S, Kanayama N, Belayet HM, Bhuiyan AB, Jahan S, Begum A, Kobayashi T, Terao T. Journal: Am J Obstet Gynecol; 2000 Apr; 182(4):896-900. PubMed ID: 10764469. Abstract: OBJECTIVE: Epinephrine and norepinephrine are associated with the hyperstimulation of the sympathetic nervous system. Neuropeptide Y is a potent vasoconstrictive substance that is released in response to sympathetic nerve stimulation. STUDY DESIGN: The concentrations of plasma neuropeptide Y in pregnant patients with eclampsia (n = 8), preeclampsia (n = 8), and normotension (n = 8) were measured by radioimmunoassay on admission and 6 days after delivery. Correlations between plasma concentration of neuropeptide Y and mean arterial blood pressure were also evaluated in these patients on admission and 6 days after delivery. RESULTS: The plasma level of neuropeptide Y in women with eclampsia (P <.001) and preeclampsia (P <.003) was found to be significantly elevated with respect to that in normotensive pregnant women. At 6 days after delivery the concentration of plasma neuropeptide Y was significantly decreased in women with eclampsia, women with preeclampsia, and women with normotensive pregnancies compared with the value measured on admission (P <.0001, P <.0001, and P <.002, respectively). At admission the plasma neuropeptide Y level was positively correlated with mean arterial blood pressure in women with eclampsia and preeclampsia. However, no significant correlations were observed between plasma neuropeptide Y concentration and mean arterial blood pressure both at admission and 6 days after delivery in normotensive pregnant women and 6 days after delivery in women with eclampsia and preeclampsia. CONCLUSION: We have concluded that the level of neuropeptide Y in plasma is increased in women with eclampsia and preeclampsia. Elevated plasma neuropeptide Y levels may play a key role in the development of eclampsia and preeclampsia. This study investigated the plasma concentrations of neuropeptide Y associated with the pre-eclamptic and eclamptic conditions. Subjects included patients in the third trimester of pregnancy admitted at Dhaka Medical College Hospital, Bangladesh, from January 1996 to March 1998 with untreated eclampsia (n = 8), pre-eclampsia (n = 8), and normotensive pregnancy (n = 8). Nonpregnant healthy volunteer women (n = 8) were also enrolled. Blood samples were collected and the concentrations of plasma neuropeptide Y were measured by radioimmunoassay on admission and 6 days after delivery. The correlations between plasma concentration of neuropeptide Y and mean arterial blood pressure were also evaluated in these patients. The findings showed that the plasma level of neuropeptide Y in women with eclampsia (P 0.001) and pre-eclampsia (P 0.003) was significantly elevated in comparison with normotensive pregnant women. At 6 days after delivery the concentration of plasma neuropeptide Y was significantly decreased in women with eclampsia, women with pre-eclampsia, and women with normotensive pregnancies compared with the value measured on admission (P 0.0001, P 0.0001, and P 0.002, respectively). At admission the plasma neuropeptide Y level was positively correlated with mean arterial blood pressure in women with eclampsia and pre-eclampsia. However, no significant correlations were observed between plasma neuropeptide Y concentration and mean arterial blood pressure both at admission and 6 days after delivery in normotensive pregnant women and 6 days after delivery in women with eclampsia and pre-eclampsia. The study concluded that the level of neuropeptide Y in plasma is increased in women with eclampsia and pre-eclampsia.[Abstract] [Full Text] [Related] [New Search]